[go: up one dir, main page]

AU2002223275A1 - A method of expression and agents identified thereby - Google Patents

A method of expression and agents identified thereby

Info

Publication number
AU2002223275A1
AU2002223275A1 AU2002223275A AU2327502A AU2002223275A1 AU 2002223275 A1 AU2002223275 A1 AU 2002223275A1 AU 2002223275 A AU2002223275 A AU 2002223275A AU 2327502 A AU2327502 A AU 2327502A AU 2002223275 A1 AU2002223275 A1 AU 2002223275A1
Authority
AU
Australia
Prior art keywords
expression
agents identified
agents
identified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002223275A
Inventor
Anthony John Mason
Simon Peter Tucker
Paul R. Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biota Scientific Management Pty Ltd
Original Assignee
Biota Scientific Management Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biota Scientific Management Pty Ltd filed Critical Biota Scientific Management Pty Ltd
Publication of AU2002223275A1 publication Critical patent/AU2002223275A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2002223275A 2000-11-22 2001-11-22 A method of expression and agents identified thereby Abandoned AU2002223275A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25276700P 2000-11-22 2000-11-22
US60/252,767 2000-11-22
PCT/AU2001/001517 WO2002042326A1 (en) 2000-11-22 2001-11-22 A method of expression and agents identified thereby

Publications (1)

Publication Number Publication Date
AU2002223275A1 true AU2002223275A1 (en) 2002-06-03

Family

ID=22957457

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002223275A Abandoned AU2002223275A1 (en) 2000-11-22 2001-11-22 A method of expression and agents identified thereby

Country Status (3)

Country Link
US (1) US20040161846A1 (en)
AU (1) AU2002223275A1 (en)
WO (1) WO2002042326A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100481879B1 (en) * 2001-02-08 2005-04-11 크레아젠 주식회사 Method for Improving a Genetic Stability for the Insert in (+)-Single-Stranded RNA Virus Recombinant Vectors
US20070020630A1 (en) 2003-03-27 2007-01-25 Trotta Christopher R Methods of identifying compounds that target trna splicing endonuclease and uses of said compounds as anti-proliferative agents
EP1613159A4 (en) 2003-03-27 2007-08-01 Ptc Therapeutics Inc Methods of identifying compounds that target trna splicing endonuclease and uses of said compounds as anti-fungal agents
JP4990621B2 (en) 2003-07-02 2012-08-01 ピーティーシー セラピューティクス，インコーポレーテッド RNA processing protein complex and use thereof
BRPI0418127A (en) 2003-12-24 2007-04-27 Biota Scient Management use of a compound, its salts, and pharmaceutically acceptable derivatives thereof, method for treating infections involving the pneumovirinae subfamily virus, pharmaceutical formulation, methods for treating infected mammals and preventing infection of mammals with subfamily viruses. pneumovirinae, compound, its salts, and pharmaceutically acceptable derivatives thereof, compound and the n-oxide and pyridinium salt thereof, and method of separating enantiomers from a compound
TWI423972B (en) 2006-09-28 2014-01-21 Biota Scient Management Polycyclic agents for the treatment of respiratory syncytial virus infections
WO2008105949A2 (en) * 2006-10-09 2008-09-04 Siemens Healthcare Diagnostics Inc. Methods of screening for respiratory synctial virus and human metapneumovirus
US8772256B2 (en) * 2006-11-30 2014-07-08 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Codon modified immunogenic compositions and methods of use
MX2009009226A (en) 2007-03-06 2009-10-28 Symphogen As Recombinant antibodies for treatment of respiratory syncytial virus infections.
EP2164860A2 (en) * 2007-06-06 2010-03-24 Nationwide Children's Hospital, Inc. Methods and compositions relating to viral fusion proteins
EP3508505A1 (en) 2007-12-24 2019-07-10 ID Biomedical Corporation of Quebec Recombinant rsv antigens
CA2721246A1 (en) * 2008-04-18 2009-10-22 Vaxinnate Corporation Deletion mutants of flagellin and methods of use
US20110177117A1 (en) * 2008-07-18 2011-07-21 Normand Blais Chimeric respiratory syncytial virus polypeptide antigens
WO2010039224A2 (en) 2008-09-30 2010-04-08 University Of Massachusetts Medical School Respiratory syncytial virus (rsv) sequences for protein expression and vaccines
KR20120093811A (en) 2009-06-24 2012-08-23 아이디 바이오메디컬 코포레이션 오브 퀘벡 vaccine
US9492531B2 (en) * 2009-06-24 2016-11-15 Glaxosmithkline Biologicals Sa Recombinant RSV vaccines
EP3178490B1 (en) 2009-07-15 2022-04-20 GlaxoSmithKline Biologicals S.A. Rsv f protein compositions and methods for making same
US20110097358A1 (en) * 2009-10-12 2011-04-28 Techno Vax, Inc. RESPIRATORY SYNCYTIAL VIRUS (RSV) VIRUS-LIKE PARTICLES (VLPs)
TWI508968B (en) 2010-02-08 2015-11-21 Biota Scient Management Compounds for treating respiratory syncytial virus infections
US8796303B2 (en) 2010-11-26 2014-08-05 Biota Scientific Management Pty Ltd. Imidazo[2,1-G][1,7]naphthyridines for treating respiratory syncytial virus infections
JP2014505477A (en) * 2011-01-28 2014-03-06 メディミューン，エルエルシー Expression of soluble viral fusion glycoproteins in mammalian cells
SG194755A1 (en) 2011-05-13 2013-12-30 Novartis Ag Pre-fusion rsv f antigens
AU2012292947B2 (en) 2011-08-05 2017-02-16 Biota Scientific Management Pty Ltd Compounds for treating respiratory syncytial virus infections
CA2900713A1 (en) 2013-02-08 2014-08-14 Steffen Mueller Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization
WO2015041924A2 (en) * 2013-09-18 2015-03-26 Medimmune, Llc Recombinant respiratory syncytial virus (rsv) and caccines
EP3515930A1 (en) 2016-09-23 2019-07-31 The U.S.A. As Represented By The Secretary, Department Of Health And Human Services Vaccine candidates for human respiratory syncytial virus (rsv) having attenuated phenotypes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619942A (en) * 1982-04-08 1986-10-28 University Of North Carolina Inhibition of Respiratory Syncytial virus-induced cell fusion by amidino compounds
US5786464C1 (en) * 1994-09-19 2012-04-24 Gen Hospital Corp Overexpression of mammalian and viral proteins
DE69510207T3 (en) * 1995-08-09 2007-02-15 Schweiz. Serum- & Impfinstitut Bern Process for producing infectious minus-stranded RNA viruses
EP1002091B1 (en) * 1997-07-09 2012-02-29 Coridon Pty Limited Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue
US6814968B1 (en) * 1998-06-04 2004-11-09 Vanderbilt University Inhibition of viral infection and spread with viral and RhoA-derived peptides
US6924365B1 (en) * 1998-09-29 2005-08-02 Transkaryotic Therapies, Inc. Optimized messenger RNA
JP2002533124A (en) * 1998-12-31 2002-10-08 カイロン コーポレイション Improved expression of HIV polypeptide and generation of virus-like particles

Also Published As

Publication number Publication date
WO2002042326A8 (en) 2002-09-06
US20040161846A1 (en) 2004-08-19
WO2002042326A1 (en) 2002-05-30

Similar Documents

Publication Publication Date Title
AU2002223275A1 (en) A method of expression and agents identified thereby
AU2001269511A1 (en) Resilient Bush and Method of Pressure-Insertion of a Resilient Bush
EP1306573A4 (en) Resilient bush and method of pressure-insertion of a resilient bush
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU4500901A (en) A method of performing a transaction
AU2001226648A1 (en) Transport arrangement and method of controlling a transport arrangement
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2001265052A1 (en) Package kit and method
AU2001281078A1 (en) A mem gyroscope and a method of making same
AU2000278326A1 (en) Interactive and animated mini-theater and method of use
AU2000256360A1 (en) Method of providing a fire barrier and article therefor
AU2001279850A1 (en) Method and arrangement for studsystem
AUPQ582400A0 (en) A method of treatment and agents for use therein
AUPQ614700A0 (en) A method and agents useful for same
AU2002215876A1 (en) Structural member and a method of manufacturing said member
AUPQ592100A0 (en) A method of treatment and prophylaxis
AU2002256556A1 (en) Sea-trosy and related methods
AUPQ639300A0 (en) Method of enhancing or maintaining a relationship
HUP0105421A2 (en) Shaped part and a method of forming same
AUPQ199999A0 (en) A method of treatment and agents useful for same
AUPQ656500A0 (en) A method of treatment and agents for same
AUPR666501A0 (en) A method for selection and agents useful for same
AUPQ645500A0 (en) A method of treatment and agents useful for same
AUPQ800300A0 (en) A method of treatment and agents useful for same
AUPQ762100A0 (en) A method of prophylaxis and treatment - III